Vincerx Pharma, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.21 | -$0.21 | -$0.21 |
| Q2 2024 | 3 | -$0.29 | -$0.17 | -$0.22 |
| Q3 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Vincerx Pharma, Inc. Earnings Date And Information
Vincerx Pharma, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.17 by $0.12. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Vincerx Pharma, Inc. has generated $-2 earnings per share over the last year ($-1.89 diluted earnings per share) and currently has a price-to-earnings ratio of -0.51. Vincerx Pharma, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Vincerx Pharma, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.17 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.17 | -$0.05 | 0.12 | $0 | $0 |
| 05/14/2024 | Q1 2024 | -$0.26 | -$0.58 | -0.32 | $0 | |
| 03/29/2024 | Q4 2023 | -$0.42 | -$0.23 | 0.19 | $1.31 M | |
| 09/29/2023 | Q3 2023 | -$0.46 | $0 | |||
| 08/07/2023 | Q2 2023 | -$0.65 | -$0.52 | 0.13 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.69 | -$0.64 | 0.05 | $0 | |
| 03/28/2023 | Q4 2022 | -$0.63 | -$0.26 | 0.37 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.80 | -$0.80 | 0 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.92 | -$0.82 | 0.1 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.76 | -$0.54 | 0.22 | $0 | |
| 03/29/2022 | Q4 2021 | -$0.93 | -$0.31 | 0.62 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.85 | -$1.39 | -0.54 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.37 | -$0.12 | 0.25 | $0 | |
| 05/17/2021 | Q1 2021 | -$0.32 | -$0.46 | -0.14 | $127,000 | |
| 03/22/2021 | Q4 2020 | -$1.98 | $-1,400,000 | |||
| 11/10/2020 | Q3 2020 | -$0.06 | $0 | |||
| 09/23/2020 | Q2 2020 | -$0.01 | $0 | |||
| 05/06/2020 | Q1 2020 | -$0.00 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.00 | $0 |
Vincerx Pharma, Inc. Earnings: Frequently Asked Questions
-
When is Vincerx Pharma, Inc.'s earnings date?
Vincerx Pharma, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
Did Vincerx Pharma, Inc. beat their earnings estimates last quarter?
In the previous quarter, Vincerx Pharma, Inc. (:VINC) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.17 by $0.12.
-
How can I listen to Vincerx Pharma, Inc.'s earnings conference call?
The conference call for Vincerx Pharma, Inc.'s latest earnings report can be listened to online.
-
How can I read Vincerx Pharma, Inc.'s conference call transcript?
The conference call transcript for Vincerx Pharma, Inc.'s latest earnings report can be read online.
-
How much profit does Vincerx Pharma, Inc. generate each year?
Vincerx Pharma, Inc. (:VINC) has a recorded net income of $0. Vincerx Pharma, Inc. has generated $-1.89 earnings per share over the last four quarters.
-
What is Vincerx Pharma, Inc.'s price-to-earnings ratio?
Vincerx Pharma, Inc. (:VINC) has a price-to-earnings ratio of -0.51 and price/earnings-to-growth ratio is -0.02.
